应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
IRON Disc Medicine
盘后交易 03-24 16:24:32 EDT
59.61
+0.50
+0.85%
盘后
59.61
+0.00
0.00%
16:10 EDT
最高
60.33
最低
58.15
成交量
56.55万
今开
59.00
昨收
59.11
日振幅
3.69%
总市值
22.75亿
流通市值
19.60亿
总股本
3,816万
成交额
3,360万
换手率
1.72%
流通股本
3,289万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Disc Medicine高管表示：若后期试验成功，公司将选择传统审批路径而非加速通道
美股速递 · 02-17
Disc Medicine高管表示：若后期试验成功，公司将选择传统审批路径而非加速通道
Disc Medicine公司：FDA确认Aurora与Beacon试验提供充分证据，证明Bitopertin显著降低Ppix水平
美股速递 · 02-14
Disc Medicine公司：FDA确认Aurora与Beacon试验提供充分证据，证明Bitopertin显著降低Ppix水平
Disc Medicine, Inc.盘中异动 早盘大幅跳水5.02%报71.00美元
市场透视 · 02-12
Disc Medicine, Inc.盘中异动 早盘大幅跳水5.02%报71.00美元
独家：FDA推迟赛诺菲糖尿病药物Tzield与Disc Medicine血液疾病药物审评时间表 - 文件披露
美股速递 · 01-15
独家：FDA推迟赛诺菲糖尿病药物Tzield与Disc Medicine血液疾病药物审评时间表 - 文件披露
Disc Medicine称与FDA就比托普汀的沟通仍具建设性——市场快讯
投资观察 · 01-14
Disc Medicine称与FDA就比托普汀的沟通仍具建设性——市场快讯
Disc Medicine, Inc.盘中异动 早盘股价大跌5.34%报85.61美元
市场透视 · 2025-12-19
Disc Medicine, Inc.盘中异动 早盘股价大跌5.34%报85.61美元
小鹏IRON机器人将于5年内进入家庭
车质网 · 2025-11-19
小鹏IRON机器人将于5年内进入家庭
外媒：人形机器人IRON动作过于逼真引质疑 小鹏发布会现场切开机器人
环球网 · 2025-11-09
外媒：人形机器人IRON动作过于逼真引质疑 小鹏发布会现场切开机器人
汽车行业周报：马斯克薪酬方案通过 小鹏发布全新IRON机器人
方正证券 · 2025-11-09
汽车行业周报：马斯克薪酬方案通过 小鹏发布全新IRON机器人
何小鹏称心酸：走出猫步的人形机器人IRON受质疑 心中的成见像大山，束缚了我们
雷递智驾 · 2025-11-07
何小鹏称心酸：走出猫步的人形机器人IRON受质疑 心中的成见像大山，束缚了我们
何小鹏一镜到底“扒了”机器人IRON“皮肤”：原来里面没有人……
三言Pro · 2025-11-06
何小鹏一镜到底“扒了”机器人IRON“皮肤”：原来里面没有人……
小鹏将在2026年底规模化量产高阶机器人IRON
人民财讯 · 2025-11-05
小鹏将在2026年底规模化量产高阶机器人IRON
Disc Medicine宣布将在第67届美国血液学会年会上展示针对骨髓纤维化（Mf）和贫血患者的Rally-Mf II期试验初步数据
美股速递 · 2025-11-03
Disc Medicine宣布将在第67届美国血液学会年会上展示针对骨髓纤维化（Mf）和贫血患者的Rally-Mf II期试验初步数据
Disc Medicine已定价扩大规模的证券发行
环球市场播报 · 2025-10-21
Disc Medicine已定价扩大规模的证券发行
Disc Medicine宣布2.5亿美元增发普通股及预先融资认股权证的定价
美股速递 · 2025-10-21
Disc Medicine宣布2.5亿美元增发普通股及预先融资认股权证的定价
Disc Medicine加快推进Bitopertin在美国的早期审批和商业化进程
美股速递 · 2025-10-20
Disc Medicine加快推进Bitopertin在美国的早期审批和商业化进程
Disc Medicine - 年底前将公布Mf贫血II期研究初步数据，2026年公布主要数据
美股速递 · 2025-10-20
Disc Medicine - 年底前将公布Mf贫血II期研究初步数据，2026年公布主要数据
Disc Medicine更新其血液学产品组合，并概述近期商业目标及预期里程碑
美股速递 · 2025-10-20
Disc Medicine更新其血液学产品组合，并概述近期商业目标及预期里程碑
FDA：预计在未来几个月内公布另一批专员国家优先券的接受者
美股速递 · 2025-10-17
FDA：预计在未来几个月内公布另一批专员国家优先券的接受者
Disc Medicine向美国FDA递交Bitopertin新药申请，寻求治疗红细胞生成性原卟啉症的加速审批
美股速递 · 2025-09-30
Disc Medicine向美国FDA递交Bitopertin新药申请，寻求治疗红细胞生成性原卟啉症的加速审批
加载更多
公司概况
公司名称：
Disc Medicine
所属市场：
NASDAQ
上市日期：
--
主营业务：
Disc Medicine,Inc.于2020年6月25日作为特拉华州公司注册成立。该公司是一家临床阶段的生物制药公司，专注于为严重血液疾病开发新型疗法。其研发管线针对红细胞生成和功能中的基本生物学通路，主要候选药物bitopertin正被开发用于治疗红细胞生成性卟啉症，其他候选药物则针对贫血及相关疾病。
发行价格：
--
{"stockData":{"symbol":"IRON","market":"US","secType":"STK","nameCN":"Disc Medicine","latestPrice":59.61,"timestamp":1774382400000,"preClose":59.11,"halted":0,"volume":565535,"hourTrading":{"tag":"盘后","latestPrice":59.61,"preClose":59.61,"latestTime":"16:10 EDT","volume":20536,"amount":1224150.96,"timestamp":1774383004551,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.00845880561664693,"floatShares":32885100,"shares":38160065,"eps":-6.011616,"marketStatus":"盘后交易","change":0.5,"latestTime":"03-24 16:24:32 EDT","open":59,"high":60.325,"low":58.145,"amount":33595299.589495,"amplitude":0.03688,"askPrice":60.77,"askSize":32,"bidPrice":58.46,"bidSize":34,"shortable":3,"etf":0,"ttmEps":-6.011616,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1774396800000},"marketStatusCode":4,"adr":0,"listingDate":1597204800000,"exchange":"NASDAQ","adjPreClose":59.11,"preHourTrading":{"tag":"盘前","latestPrice":59.04,"preClose":59.11,"latestTime":"09:29 EDT","volume":220,"amount":12978.8384,"timestamp":1774358999999,"change":-0.07,"changeRate":-0.001184,"amplitude":0.037523},"postHourTrading":{"tag":"盘后","latestPrice":59.61,"preClose":59.61,"latestTime":"16:10 EDT","volume":20536,"amount":1224150.96,"timestamp":1774383004551,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.711281,"impliedVol":0.554,"impliedVolPercentile":0.251},"requestUrl":"/m/hq/s/IRON","defaultTab":"news","newsList":[{"id":"1120019991","title":"Disc Medicine高管表示：若后期试验成功，公司将选择传统审批路径而非加速通道","url":"https://stock-news.laohu8.com/highlight/detail?id=1120019991","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1120019991?lang=zh_cn&edition=full","pubTime":"2026-02-17 21:17","pubTimestamp":1771334232,"startTime":"0","endTime":"0","summary":"Disc Medicine高管在电话会议中透露，如果公司当前进行的后期临床试验取得积极成果，将优先考虑通过传统审批途径向监管机构提交上市申请，而非选择加速审批通道。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IRON","LU0053671581.USD"],"gpt_icon":0},{"id":"1105734608","title":"Disc Medicine公司：FDA确认Aurora与Beacon试验提供充分证据，证明Bitopertin显著降低Ppix水平","url":"https://stock-news.laohu8.com/highlight/detail?id=1105734608","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1105734608?lang=zh_cn&edition=full","pubTime":"2026-02-14 04:06","pubTimestamp":1771013171,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局（FDA）已正式认可，由Disc Medicine公司开展的Aurora及Beacon临床试验所提交的数据充分证明，其在研药物Bitopertin能够显著降低患者血液中的原卟啉（Ppix）水平。这一关键进展为Bitopertin的后续开发及潜在获批奠定了重要基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0053671581.USD","BK4139","IRON"],"gpt_icon":0},{"id":"2611973938","title":"Disc Medicine, Inc.盘中异动 早盘大幅跳水5.02%报71.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2611973938","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611973938?lang=zh_cn&edition=full","pubTime":"2026-02-12 00:22","pubTimestamp":1770826946,"startTime":"0","endTime":"0","summary":"北京时间2026年02月12日00时22分，Disc Medicine, Inc.股票出现异动，股价大幅下跌5.02%。Disc Medicine, Inc.股票所在的生物技术行业中，整体跌幅为0.57%。其相关个股中，Quince Therapeutics, Inc.、Ernexa Therapeutics Inc C/Wts 04/02/2030、内克塔治疗涨幅较大，Pmgc Holdings Inc.、Quince Therapeutics, Inc.、Aspire Biopharma Holdings, Inc.较为活跃，换手率分别为2237.49%、608.53%、188.02%，振幅较大的相关个股有Briacell Therapeutics Corp C/Wts 26/02/2026、Quince Therapeutics, Inc.、Ernexa Therapeutics Inc C/Wts 04/02/2030，振幅分别为49.15%、46.56%、45.00%。Disc Medicine, Inc.公司简介：Disc Medicine Inc 是一家临床阶段的生物制药公司，专注血液病新疗法的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021200222797a5d60f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021200222797a5d60f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IRON","LU0053671581.USD"],"gpt_icon":0},{"id":"1104011542","title":"独家：FDA推迟赛诺菲糖尿病药物Tzield与Disc Medicine血液疾病药物审评时间表 - 文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1104011542","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1104011542?lang=zh_cn&edition=full","pubTime":"2026-01-15 19:01","pubTimestamp":1768474878,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局已决定推迟对赛诺菲安万特旗下糖尿病治疗药物Tzield以及Disc Medicine公司血液疾病治疗药物的审评时间表。业内观察人士指出，FDA的审评延期通常涉及对补充数据或生产信息的进一步核查，这属于新药审评流程中的常规环节。对于赛诺菲安万特而言，Tzield作为其糖尿病管线的重要候选药物，审评进度的变化将直接影响该产品的上市时间表。而Disc Medicine的血液疾病药物同样面临关键审评节点，此次延期将对公司的研发里程碑产生连锁影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1280957306.USD","SG9999018865.SGD","LU0320765992.SGD","LU2468319806.SGD","LU2023250843.SGD","LU1291159041.SGD","LU0114720955.EUR","LU0238689110.USD","IE00BJJMRY28.SGD","LU0320765489.SGD","IE0009355771.USD","LU1267930730.SGD","IE00BBT3K403.USD","LU0061475181.USD","LU0130102774.USD","LU1989772840.SGD","LU1929549753.HKD","LU0965509101.SGD","SG9999001440.SGD","LU2360106947.USD","LU1069344957.HKD","LU2750360641.GBP","LU0109391861.USD","LU1585245621.USD","LU2106854487.HKD","LU1941712264.USD","LU0079474960.USD","LU0265550946.USD","IE00B1BXHZ80.USD","LU0417517546.SGD","LU0130517989.USD","LU1035773651.USD","LU2237443465.HKD","LU2471134523.USD","IE00BJJMRZ35.SGD","LU2237443895.HKD","LU0266013472.USD","IE00BJLML261.HKD","LU0097036916.USD","LU0203202063.USD","LU0353189763.USD","LU0672654240.SGD","LU2324357040.USD","LU2361044949.HKD","LU2237443978.SGD","SGXZ99366536.SGD","LU0985320562.USD","LU0106261372.USD","LU2237443549.SGD","LU2125154935.USD","IE0004445015.USD","IE00BWXC8680.SGD","LU0203345920.USD","LU1093756168.USD","IE00BFTCPJ56.SGD","LU1551013342.USD","LU1868836757.USD","IE0005OL40V9.USD","LU0354030511.USD","LU1699723380.USD","LU1868836914.USD","LU1116320737.USD","IE00B4JS1V06.HKD","IE00B2B36J28.USD","LU0943347566.SGD","LU1712237335.SGD","LU1057294990.SGD","LU2063271972.USD","LU0882574139.USD","SG9999014906.USD","LU1323610961.USD","SG9999001176.USD","IE00BSNM7G36.USD","LU2168564495.EUR","LU1066051225.USD","LU1571399168.USD","SG9999015341.SGD","SG9999018857.SGD","LU0648001328.SGD","IE00BJJMRX11.SGD","LU2417539215.USD","SNY","LU0385154629.USD","LU0432979614.USD","LU0965509010.AUD","LU2471134796.USD","LU2491050154.USD","IE00B775H168.HKD","LU0708995401.HKD","IE00B7KXQ091.USD","LU1720051108.HKD","SG9999001176.SGD","BK4533","BK4588","IE00BFSS8Q28.SGD","LU1983299246.USD","BK4550","LU0354030438.USD","LU2552382132.HKD","LU0070302665.USD","BK4599","LU0203201768.USD","LU0965509283.SGD","LU2746668461.USD","LU0471298694.HKD","SG9999014542.SGD","LU0786609619.USD","LU0683600562.USD","BK4516","LU2168564065.EUR","IE00BKDWB100.SGD","LU0225283273.USD","LU1232071149.USD","LU1623119135.USD","LU0889565916.HKD","LU1917777945.USD","BK4559","LU0098860793.USD","LU1066051811.HKD","LU2361045086.USD","LU2750360997.AUD","SG9999017495.SGD","SGXZ51526630.SGD","LU0289739699.SGD","LU0353189680.USD","LU2112291526.USD","LU0823434583.USD","SG9999014567.USD","IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","LU0198837287.USD","LU0208291251.USD","LU1804176565.USD","IRON","LU1548497426.USD","LU2237443382.USD","LU1066053197.SGD","IE00BK4W5L77.USD","LU0980610538.SGD","LU1061106388.HKD","LU2168564222.USD","LU0477156953.USD","LU0861579265.USD","LU0787776722.HKD","LU1814569148.SGD","LU1934455194.USD","LU0320765646.SGD","LU2360032135.SGD","LU1868837136.USD","BK4139","LU0122379950.USD","LU1037948541.HKD","LU1366192091.USD","LU0211331839.USD","LU2471134879.HKD","LU0689472784.USD","SG9999013999.USD","LU0965508806.USD","LU2461242641.AUD","LU0823416689.USD","LU1430594728.SGD","LU2491049909.HKD","BK4581","LU2552382215.SGD","LU2211815571.USD","SG9999014880.SGD","LU0820561909.HKD","LU1201861249.SGD","LU2462157665.USD","SG9999014898.SGD","LU0456855351.SGD","LU2237438978.USD","LU2357305700.SGD","BK4534","LU0234572021.USD","LU1934455277.USD","SGXZ57979304.SGD","LU2746668974.SGD","LU0466842654.USD","LU2264538146.SGD","SG9999002224.SGD","LU2602419157.SGD","LU1066051498.USD","SG9999014575.USD","IE0004445239.USD","SGXZ81514606.USD","SG9999015358.SGD","LU0820561818.USD","IE00BN8TJ469.HKD","LU1037948897.HKD","LU2265009873.SGD","LU2089984988.USD","LU1162221912.USD","LU0109394709.USD","SG9999014559.SGD","LU0053671581.USD","SG9999015986.USD","LU2552382058.USD","LU2361044865.SGD","LU0882574055.USD","SG9999015952.SGD","GB00BDT5M118.USD","IE00BLSP4239.USD","IE00BLSP4452.SGD","LU1023059063.AUD","LU0094547139.USD","LU1989772923.USD","LU2237443622.USD","LU1116320901.HKD","LU0256863811.USD","SG9999015945.SGD","LU2087625088.SGD","LU2168564149.EUR","LU1989771016.USD","LU1127390331.HKD","IE0002141913.USD","BK4007","BK4585","IE00B1XK9C88.USD","LU1093756325.SGD","LU0058720904.USD","LU0265550359.USD","SG9999014914.USD","LU2236285917.USD","LU0096364046.USD","LU0823434740.USD","LU0203347892.USD","LU1064131342.USD","IE000M9KFDE8.USD","LU1868837300.USD","LU2471134952.CNY","LU2023250504.SGD","LU1988902786.USD","LU1934455863.HKD","LU0471298777.SGD","LU1974910355.USD","IE00BKPKM429.USD","LU2125154778.USD","LU0006306889.USD","LU0320765059.SGD","LU1868836591.USD","LU1941712348.USD","LU2491050071.SGD","SG9999015978.USD","LU1069347547.HKD","LU1035775433.USD","IE00BN29S564.USD","IE00BK4W5M84.HKD","LU1551013425.SGD","LU1720051017.SGD","SGXZ31699556.SGD","LU2108987350.USD","SG9999002232.USD","LU0323591593.USD","LU2168563687.JPY","LU2456880835.USD","LU0256863902.USD","LU0316494557.USD","IE00BFSS7M15.SGD","LU0640476718.USD"],"gpt_icon":0},{"id":"1164925448","title":"Disc Medicine称与FDA就比托普汀的沟通仍具建设性——市场快讯","url":"https://stock-news.laohu8.com/highlight/detail?id=1164925448","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1164925448?lang=zh_cn&edition=full","pubTime":"2026-01-14 03:18","pubTimestamp":1768331911,"startTime":"0","endTime":"0","summary":"Disc Medicine管理层在摩根大通医疗健康大会上的一场分析师活动中重申，其与美国食品药品监督管理局就比托普汀获批事宜的沟通依然富有成效。据BMO发布的一份报告指出，该公司正试图消除投资者因STAT News的一篇报道而产生的担忧，该报道称生物制品评价与研究中心主任Vinay Prasad对比托普汀的申请持怀疑态度。分析师还补充道，BMO对Disc Medicine就该药物所做的商业化准备工作印象深刻。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IRON","BK4139","LU0053671581.USD"],"gpt_icon":0},{"id":"2592114160","title":"Disc Medicine, Inc.盘中异动 早盘股价大跌5.34%报85.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2592114160","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592114160?lang=zh_cn&edition=full","pubTime":"2025-12-19 23:04","pubTimestamp":1766156641,"startTime":"0","endTime":"0","summary":"北京时间2025年12月19日23时04分，Disc Medicine, Inc.股票出现波动，股价快速下跌5.34%。截至发稿，该股报85.61美元/股，成交量31.0951万股，换手率0.82%，振幅6.34%。Disc Medicine, Inc.股票所在的生物技术行业中，整体涨幅为1.10%。Disc Medicine, Inc.公司简介：Disc Medicine Inc 是一家临床阶段的生物制药公司，专注血液病新疗法的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025121923040297a07fb6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025121923040297a07fb6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IRON","BK4139","LU0053671581.USD"],"gpt_icon":0},{"id":"2584998146","title":"小鹏IRON机器人将于5年内进入家庭","url":"https://stock-news.laohu8.com/highlight/detail?id=2584998146","media":"车质网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584998146?lang=zh_cn&edition=full","pubTime":"2025-11-19 09:05","pubTimestamp":1763514300,"startTime":"0","endTime":"0","summary":"在小鹏Q3业绩会后续QA环节中，大师兄XP-何小鹏 称：什么时候机器人可以进入家庭？另外，他还称：IRON将于2030年销量达100万台。IRON的量产有特别多的挑战，我们期望IRON最后可以是一个能用语言沟通并且让它做事情的机器人，我们希望它是一个可以通过简单教导、培训就可以干活的机器人。小鹏汽车希望最开始机器人能够在商业场景，包括导购、导览、前台以及导寻的商业化场景落地。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251119090645950d45a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251119090645950d45a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","EVS.SI","BK4505","BK4551","LU0053671581.USD","BK4526","IRON","BK4555","XPEV","09868","BK4099"],"gpt_icon":1},{"id":"2582933678","title":"外媒：人形机器人IRON动作过于逼真引质疑 小鹏发布会现场切开机器人","url":"https://stock-news.laohu8.com/highlight/detail?id=2582933678","media":"环球网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582933678?lang=zh_cn&edition=full","pubTime":"2025-11-09 12:05","pubTimestamp":1762661106,"startTime":"0","endTime":"0","summary":"小鹏汽车近日正式发布名为IRON的人形机器人，其流畅自然的动作与先进的人工智能引发广泛关注。由于动作过于逼真，不少观众怀疑这实为真人伪装。为回应质疑，小鹏在发布会现场直接切割机器人外壳，展示其内部机械结构。董事长兼CEO何小鹏亲自登台澄清，证实IRON完全由机械与AI驱动，并无人类藏身其中。目前，IRON主要面向商业场景，如商店、办公室与企业展厅。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251109120619a6ec344d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251109120619a6ec344d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","IRON","BK4099","BK4551","BK4555","EVS.SI","09868","BK4139","BK4526","XPEV"],"gpt_icon":1},{"id":"2582891518","title":"汽车行业周报：马斯克薪酬方案通过 小鹏发布全新IRON机器人","url":"https://stock-news.laohu8.com/highlight/detail?id=2582891518","media":"方正证券","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582891518?lang=zh_cn&edition=full","pubTime":"2025-11-09 00:00","pubTimestamp":1762617600,"startTime":"0","endTime":"0","summary":"年末车购税优惠政策即将到期，预计Q4 消费者购车热情仍将保持高位。2）特斯拉股东大会召开：①马斯克“万亿美元薪酬方案”获超过75%的股东批准；②2026 年将启动第三代机器人生产，预计27/28 年推出第四/第五代机器人，规模量产生产成本目标控制在2 万美元。3）小鹏发布全新IRON 人形机器人：IRON 采用“由内而生”的仿生结构，搭载全固态电池及小鹏自研的“物理世界大模型”，小鹏已实现多项关键零部件自研，目标2026 年底量产。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110918162994f91ad4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110918162994f91ad4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4598","01211","BK4543","LU2420271590.USD","LU1066051225.USD","LU0820562030.AUD","SG9999015986.USD","BK4534","LU1551013425.SGD","LU1861215975.USD","03808","BK4581","LU0466842654.USD","LU0316494557.USD","00699","BK4527","XPEV","IE00BSNM7G36.USD","09927","LU2756315664.SGD","EVS.SI","00175","09868","02050","LU1720051017.SGD","LU0210536198.USD","LU2249611893.SGD","BK4139","LU1839511570.USD","LU2360106780.USD","LU0323591593.USD","LU1720051108.HKD","LU2290526834.HKD","DXYZ","LU2108987350.USD","LU2087621335.USD","IE00BK4W5M84.HKD","TSYW.SI","LU1852331112.SGD","IRON","LU2357305700.SGD","IE00BWXC8680.SGD","IE00B19Z8X17.USD","UFO","LU0234572021.USD","LU2750360641.GBP","09660","BK4592","LU2236285917.USD","SG9999015945.SGD","LU2023250330.USD","LU0053666078.USD","LU2471134879.HKD","LU2063271972.USD","LU1066051811.HKD","SG9999015978.USD","LU1778281490.HKD"],"gpt_icon":1},{"id":"2581882478","title":"何小鹏称心酸：走出猫步的人形机器人IRON受质疑 心中的成见像大山，束缚了我们","url":"https://stock-news.laohu8.com/highlight/detail?id=2581882478","media":"雷递智驾","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581882478?lang=zh_cn&edition=full","pubTime":"2025-11-07 19:39","pubTimestamp":1762515585,"startTime":"0","endTime":"0","summary":"在昨日的发布会上，小鹏汽车CEO何小鹏再次请出机器人IRON，并做出行业罕见之举：在机器人通电运行状态下，现场剪开其腿部覆盖件，公开展示内部的机械结构。何小鹏说，自己的心里有一些心酸，人们不相信走出猫步的IRON是机器人，而是里面藏着一个真人。更早前，何小鹏说，当机器人拥有了拟人的骨骼、肌肉和皮肤，IRON便拥有了在物理世界中的无限可能。目前，IRON已搭载了小鹏新一代灵巧手。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251107235931a6e9265e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251107235931a6e9265e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4555","IRON","EVS.SI","BK4526","BK4551","XPEV","BK4505","BK4099","BK4139","09868"],"gpt_icon":1},{"id":"2581032312","title":"何小鹏一镜到底“扒了”机器人IRON“皮肤”：原来里面没有人……","url":"https://stock-news.laohu8.com/highlight/detail?id=2581032312","media":"三言Pro","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581032312?lang=zh_cn&edition=full","pubTime":"2025-11-06 13:28","pubTimestamp":1762406880,"startTime":"0","endTime":"0","summary":"11月5日，在小鹏科技日上，小鹏汽车推出了全新一代人形机器人IRON。很多网友在社交平台上发帖称，怀疑小鹏新一代IRON是“真人假扮”的。11月6日早上，何小鹏亲自发布一镜到底的一段视频，与小鹏机器人团队一起“辟谣”。视频中，小鹏机器人团队将IRON两只手臂和后背处的“皮肤”掀开。可以看到，IRON胳膊内是白色的类似塑料材质物体，还有条状孔洞带，何小鹏介绍称，IRON“皮肤”下就是其“肌肉”。","market":"us","thumbnail":"http://imgcloud.jrjimg.cn/2025/11/cms_20251106135546925.jpg","type":0,"news_type":0,"thumbnails":["http://imgcloud.jrjimg.cn/2025/11/cms_20251106135546925.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2025/11/06132854045407.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK4505","BK1588","BK1539","BK4139","BK4526","BK4551","LU0593848301.USD","BK1587","XPEV","BK1610","BK1575","BK4555","09868","EVS.SI","BK4099","BK1119","IRON"],"gpt_icon":1},{"id":"2581974125","title":"小鹏将在2026年底规模化量产高阶机器人IRON","url":"https://stock-news.laohu8.com/highlight/detail?id=2581974125","media":"人民财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581974125?lang=zh_cn&edition=full","pubTime":"2025-11-05 16:54","pubTimestamp":1762332883,"startTime":"0","endTime":"0","summary":"【小鹏将在2026年底规模化量产高阶机器人IRON】11月5日，何小鹏透露，小鹏将在2026年底规模化量产高阶机器人IRON。未来，IRON会优先进入商业场景提供服务，它可以像人类一样，快速融入各行各业。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"eda6c0e6f7b436f11db2f2bf22cd1374","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202511053555933216.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1588","BK4555","BK1539","BK1610","BK4505","IRON","LU0593848301.USD","BK1119","BK4551","BK1587","BK4139","XPEV","BK4099","09868","BK4526","EVS.SI","BK1575"],"gpt_icon":0},{"id":"1160382371","title":"Disc Medicine宣布将在第67届美国血液学会年会上展示针对骨髓纤维化（Mf）和贫血患者的Rally-Mf II期试验初步数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1160382371","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1160382371?lang=zh_cn&edition=full","pubTime":"2025-11-03 22:01","pubTimestamp":1762178473,"startTime":"0","endTime":"0","summary":"Disc Medicine宣布将在第67届美国血液学会年会上展示针对骨髓纤维化（Mf）和贫血患者的Rally-Mf II期试验初步数据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IRON","BK4139"],"gpt_icon":0},{"id":"2577983874","title":"Disc Medicine已定价扩大规模的证券发行","url":"https://stock-news.laohu8.com/highlight/detail?id=2577983874","media":"环球市场播报","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577983874?lang=zh_cn&edition=full","pubTime":"2025-10-21 22:57","pubTimestamp":1761058669,"startTime":"0","endTime":"0","summary":"美股周二早盘，临床阶段生物制药公司Disc Medicine（IRON）股价小幅下跌，此前该公司宣布已定价扩大规模的证券发行，以筹集2.5亿美元，收益将用于支持抗精神分裂症药物比托派汀（Bitopertin）的商业化并推进其产品管线。此次发行包括普通股和预融资权证，交易预计将于2025年10月22日完成。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：张俊 SF065","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2025-10-21/doc-infusksf4126806.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina_us","symbols":["BK4139","IRON"],"gpt_icon":0},{"id":"1180597667","title":"Disc Medicine宣布2.5亿美元增发普通股及预先融资认股权证的定价","url":"https://stock-news.laohu8.com/highlight/detail?id=1180597667","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1180597667?lang=zh_cn&edition=full","pubTime":"2025-10-21 12:15","pubTimestamp":1761020109,"startTime":"0","endTime":"0","summary":"Disc Medicine宣布2.5亿美元增发普通股及预先融资认股权证的定价","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IRON","BK4139"],"gpt_icon":0},{"id":"1195471869","title":"Disc Medicine加快推进Bitopertin在美国的早期审批和商业化进程","url":"https://stock-news.laohu8.com/highlight/detail?id=1195471869","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1195471869?lang=zh_cn&edition=full","pubTime":"2025-10-20 18:35","pubTimestamp":1760956508,"startTime":"0","endTime":"0","summary":"Disc Medicine加快推进Bitopertin在美国的早期审批和商业化进程","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IRON"],"gpt_icon":0},{"id":"1173314085","title":"Disc Medicine - 年底前将公布Mf贫血II期研究初步数据，2026年公布主要数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1173314085","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1173314085?lang=zh_cn&edition=full","pubTime":"2025-10-20 18:33","pubTimestamp":1760956388,"startTime":"0","endTime":"0","summary":"Disc Medicine - 年底前将公布Mf贫血II期研究的初步数据，预计在2026年公布主要数据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IRON"],"gpt_icon":0},{"id":"1194353114","title":"Disc Medicine更新其血液学产品组合，并概述近期商业目标及预期里程碑","url":"https://stock-news.laohu8.com/highlight/detail?id=1194353114","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1194353114?lang=zh_cn&edition=full","pubTime":"2025-10-20 18:30","pubTimestamp":1760956210,"startTime":"0","endTime":"0","summary":"Disc Medicine更新其血液学产品组合，并概述近期商业目标及预期里程碑","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IRON","BK4139"],"gpt_icon":0},{"id":"1151488115","title":"FDA：预计在未来几个月内公布另一批专员国家优先券的接受者","url":"https://stock-news.laohu8.com/highlight/detail?id=1151488115","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1151488115?lang=zh_cn&edition=full","pubTime":"2025-10-17 05:23","pubTimestamp":1760649791,"startTime":"0","endTime":"0","summary":"FDA：预计在未来几个月内公布另一批专员国家优先券的接受者","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","ACHV","IRON","REGN","RVMD","BK4588","LU1974910355.USD","LU0114720955.EUR","LU2362541273.HKD","LU0889565916.HKD","BK4139","LU0882574055.USD","LU2089984988.USD","LU0109394709.USD","LU1917777945.USD","LU0823416689.USD","LU2023250504.SGD","LU0289739699.SGD","LU2362540622.SGD","LU0823434583.USD","LU2237438978.USD","BK4585","LU2106854487.HKD","LU0058720904.USD","LU0823434740.USD","LU2362541513.USD","LU0053666078.USD","LU2468319806.SGD"],"gpt_icon":0},{"id":"1184340455","title":"Disc Medicine向美国FDA递交Bitopertin新药申请，寻求治疗红细胞生成性原卟啉症的加速审批","url":"https://stock-news.laohu8.com/highlight/detail?id=1184340455","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1184340455?lang=zh_cn&edition=full","pubTime":"2025-09-30 20:32","pubTimestamp":1759235578,"startTime":"0","endTime":"0","summary":"Disc Medicine向美国FDA递交Bitopertin新药申请，寻求治疗红细胞生成性原卟啉症的加速审批","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IRON","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.discmedicine.com","stockEarnings":[{"period":"1week","weight":-0.0292},{"period":"1month","weight":-0.0367},{"period":"3month","weight":-0.2595},{"period":"6month","weight":-0.0526},{"period":"1year","weight":0.1315},{"period":"ytd","weight":-0.2556}],"compareEarnings":[{"period":"1week","weight":-0.0204},{"period":"1month","weight":-0.0494},{"period":"3month","weight":-0.0474},{"period":"6month","weight":-0.0087},{"period":"1year","weight":0.1621},{"period":"ytd","weight":-0.0389}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Disc Medicine,Inc.于2020年6月25日作为特拉华州公司注册成立。该公司是一家临床阶段的生物制药公司，专注于为严重血液疾病开发新型疗法。其研发管线针对红细胞生成和功能中的基本生物学通路，主要候选药物bitopertin正被开发用于治疗红细胞生成性卟啉症，其他候选药物则针对贫血及相关疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.025919},{"month":2,"riseRate":0.666667,"avgChangeRate":0.005202},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.093563},{"month":4,"riseRate":0.4,"avgChangeRate":-0.012723},{"month":5,"riseRate":0.6,"avgChangeRate":0.039664},{"month":6,"riseRate":0.8,"avgChangeRate":0.10084},{"month":7,"riseRate":0.4,"avgChangeRate":-0.052496},{"month":8,"riseRate":0.8,"avgChangeRate":0.093002},{"month":9,"riseRate":0.5,"avgChangeRate":-0.006486},{"month":10,"riseRate":0.333333,"avgChangeRate":0.020523},{"month":11,"riseRate":0.666667,"avgChangeRate":0.064648},{"month":12,"riseRate":0.666667,"avgChangeRate":0.034}],"exchange":"NASDAQ","name":"Disc Medicine","nameEN":"Disc Medicine"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Disc Medicine(IRON)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Disc Medicine(IRON)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Disc Medicine,IRON,Disc Medicine股票,Disc Medicine股票老虎,Disc Medicine股票老虎国际,Disc Medicine行情,Disc Medicine股票行情,Disc Medicine股价,Disc Medicine股市,Disc Medicine股票价格,Disc Medicine股票交易,Disc Medicine股票购买,Disc Medicine股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Disc Medicine(IRON)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Disc Medicine(IRON)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}